AI-based applications for personalized cancer medicine and related regulatory challenges: An overview

Personalized therapies could improve the treatment of many diseases in the future. Cancer medicine in particular has made significant progress in recent years.

Just – Evotec Biologics awarded second contract from U.S. Department of Defense under accelerated antibodies program – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Just – Evotec Biologics awarded second contract from U.S. Department of Defense under accelerated antibodies program 05.07.2023 /

July 6, 2023

Piramidal Secures $6M to Expand Foundational AI Brain Model for Neurologists

What You Should Know: – Upstart technology innovator Piramidal has secured $6 million in seed funding to aid its development of a barrier-breaking artificial intelligence (AI)

August 21, 2024

Protocols originally intended to be extra conservative are now heralded as evidence of mifepristone’s risk

Decisions made by the Food and Drug Administration more than 20 years ago have come under heightened scrutiny thanks to a lawsuit calling for increased

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.